BACKGROUND: Glutamatergic transmission in the amygdala is hypothesized as an important mediator of stimulus-reward associations contributing to drug-seeking behavior and relapse. Insight is, however, lacking regarding the amygdala glutamatergic system in human drug abusers. METHODS: We examined glutamate receptors and scaffolding proteins associated with the postsynaptic density in the human postmortem amygdala. Messenger RNA or protein levels were studied in a population of multidrug (seven heroin, eight cocaine, seven heroin/cocaine, and seven controls) or predominant heroin (29 heroin and 15 controls) subjects. RESULTS: The amygdala of drug abusers was characterized by a striking positive correlation (r > .8) between α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid glutamate receptor subunit 1 (GluA1) and postsynaptic density protein-95 (PSD-95) mRNA levels, which was not evident in control subjects. Structural equation multigroup analysis of protein correlations also identified the relationship between GluA1 and PSD-95 protein levels as the distinguishing feature of abusers. In line with the GluA1-PSD-95 implications of enhanced synaptic plasticity, Homer 1b/c protein expression was increased in both heroin and cocaine users as was its binding partner, dynamin-3. Furthermore, there was a positive relationship between Homer 1b/c and dynamin-3 in drug abusers that reflected an increase in the direct physical coupling between the proteins. A noted age-related decline of Homer 1b/c-dynamin-3 interactions, as well as GluA1 levels, was blunted in abusers. CONCLUSIONS: Impairment of key components of the amygdala postsynaptic density and coupling to the endocytic zone, critical for the regulation of glutamate receptor cycling, may underlie heightened synaptic plasticity in human drug abusers. Copyright Â
BACKGROUND: Glutamatergic transmission in the amygdala is hypothesized as an important mediator of stimulus-reward associations contributing to drug-seeking behavior and relapse. Insight is, however, lacking regarding the amygdala glutamatergic system in human drug abusers. METHODS: We examined glutamate receptors and scaffolding proteins associated with the postsynaptic density in the human postmortem amygdala. Messenger RNA or protein levels were studied in a population of multidrug (seven heroin, eight cocaine, seven heroin/cocaine, and seven controls) or predominant heroin (29 heroin and 15 controls) subjects. RESULTS: The amygdala of drug abusers was characterized by a striking positive correlation (r > .8) between α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid glutamate receptor subunit 1 (GluA1) and postsynaptic density protein-95 (PSD-95) mRNA levels, which was not evident in control subjects. Structural equation multigroup analysis of protein correlations also identified the relationship between GluA1 and PSD-95 protein levels as the distinguishing feature of abusers. In line with the GluA1-PSD-95 implications of enhanced synaptic plasticity, Homer 1b/c protein expression was increased in both heroin and cocaine users as was its binding partner, dynamin-3. Furthermore, there was a positive relationship between Homer 1b/c and dynamin-3 in drug abusers that reflected an increase in the direct physical coupling between the proteins. A noted age-related decline of Homer 1b/c-dynamin-3 interactions, as well as GluA1 levels, was blunted in abusers. CONCLUSIONS: Impairment of key components of the amygdala postsynaptic density and coupling to the endocytic zone, critical for the regulation of glutamate receptor cycling, may underlie heightened synaptic plasticity in human drug abusers. Copyright Â
Authors: Jiuyi Lu; Thomas D Helton; Thomas A Blanpied; Bence Rácz; Thomas M Newpher; Richard J Weinberg; Michael D Ehlers Journal: Neuron Date: 2007-09-20 Impact factor: 17.173
Authors: Weifeng Xu; Oliver M Schlüter; Pascal Steiner; Brian L Czervionke; Bernardo Sabatini; Robert C Malenka Journal: Neuron Date: 2008-01-24 Impact factor: 17.173
Authors: Karen K Szumlinski; Kenneth E Abernathy; Erik B Oleson; Matthias Klugmann; Kevin D Lominac; Dao-Yao He; Dorit Ron; Matthew During; Peter W Kalivas Journal: Neuropsychopharmacology Date: 2006-04 Impact factor: 7.853
Authors: Sharon M Anderson; Katie R Famous; Ghazaleh Sadri-Vakili; Vidhya Kumaresan; Heath D Schmidt; Caroline E Bass; Ernest F Terwilliger; Jang-Ho J Cha; R Christopher Pierce Journal: Nat Neurosci Date: 2008-02-17 Impact factor: 24.884
Authors: Wendy J Lynch; Alexis B Peterson; Victoria Sanchez; Jean Abel; Mark A Smith Journal: Neurosci Biobehav Rev Date: 2013-06-24 Impact factor: 8.989
Authors: Gabor Egervari; Joseph Landry; James Callens; John F Fullard; Panos Roussos; Eva Keller; Yasmin L Hurd Journal: Biol Psychiatry Date: 2016-09-28 Impact factor: 13.382
Authors: Sarah Ann R Anderson; Michael Michaelides; Parisa Zarnegar; Yanhua Ren; Pernilla Fagergren; Panayotis K Thanos; Gene-Jack Wang; Michael Bannon; John F Neumaier; Eva Keller; Nora D Volkow; Yasmin L Hurd Journal: J Clin Invest Date: 2013-11-15 Impact factor: 14.808
Authors: Stephanie E Sillivan; John D Whittard; Michelle M Jacobs; Yanhua Ren; Amin R Mazloom; Francesca F Caputi; Monika Horvath; Eva Keller; Avi Ma'ayan; Ying-Xian Pan; Lillian W Chiang; Yasmin L Hurd Journal: Biol Psychiatry Date: 2013-05-20 Impact factor: 13.382